MX170801B - Composicion farmaceutica para la prevencion de las enfermedades sexualmente transmisibles - Google Patents
Composicion farmaceutica para la prevencion de las enfermedades sexualmente transmisiblesInfo
- Publication number
- MX170801B MX170801B MX016734A MX1673489A MX170801B MX 170801 B MX170801 B MX 170801B MX 016734 A MX016734 A MX 016734A MX 1673489 A MX1673489 A MX 1673489A MX 170801 B MX170801 B MX 170801B
- Authority
- MX
- Mexico
- Prior art keywords
- prevention
- pharmaceutical composition
- sexually
- communicable diseases
- est
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Reproductive Health (AREA)
- Virology (AREA)
- Urology & Nephrology (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gynecology & Obstetrics (AREA)
- AIDS & HIV (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Absorbent Articles And Supports Therefor (AREA)
Abstract
La presente invención se refiere a composición farmacéutica para la prevención de las enfermedades sexualmente transmisibles (EST") destinada para ser puesta en contacto con una mucosa, caracterizada porque incluye, por una parte por lo menos un principio activo contra virus o bacterias responsables de las mensionadas EST y, por otra parte, un producto inhibidor de penetración de dicho principio activo a traves de la mucusa, en combinación con un vehículo farmaceuticamente aceptable adaptado para una administración por vía tópica de esta composición.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8809418 | 1988-07-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX170801B true MX170801B (es) | 1993-09-14 |
Family
ID=9368330
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX016734A MX170801B (es) | 1988-07-11 | 1989-07-10 | Composicion farmaceutica para la prevencion de las enfermedades sexualmente transmisibles |
Country Status (38)
Country | Link |
---|---|
US (1) | US5439685A (es) |
EP (1) | EP0351301B1 (es) |
JP (1) | JPH0774164B2 (es) |
KR (1) | KR0143231B1 (es) |
CN (1) | CN1035038C (es) |
AP (1) | AP108A (es) |
AR (1) | AR243381A1 (es) |
AT (1) | ATE97570T1 (es) |
BR (1) | BR8903523A (es) |
CA (1) | CA1341304C (es) |
CZ (1) | CZ280722B6 (es) |
DD (1) | DD283932A5 (es) |
DE (1) | DE68910892T2 (es) |
DK (1) | DK173527B1 (es) |
ES (1) | ES2062065T3 (es) |
FI (1) | FI101595B (es) |
HK (1) | HK131095A (es) |
HU (1) | HU206634B (es) |
IE (1) | IE63115B1 (es) |
IL (1) | IL90910A (es) |
LT (1) | LT3754B (es) |
LV (1) | LV10573B (es) |
MA (1) | MA22036A1 (es) |
MD (1) | MD406C2 (es) |
MX (1) | MX170801B (es) |
MY (1) | MY106242A (es) |
NO (1) | NO178843C (es) |
NZ (1) | NZ229891A (es) |
OA (1) | OA09123A (es) |
PL (1) | PL161848B1 (es) |
PT (1) | PT91108B (es) |
RU (1) | RU2065742C1 (es) |
SK (1) | SK423889A3 (es) |
TN (1) | TNSN89074A1 (es) |
TR (1) | TR28353A (es) |
UA (1) | UA26124A (es) |
YU (1) | YU47899B (es) |
ZA (1) | ZA895263B (es) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02258718A (ja) * | 1989-03-31 | 1990-10-19 | Nippon Kayaku Co Ltd | ペースト状基剤及び製剤 |
US5795870A (en) * | 1991-12-13 | 1998-08-18 | Trustees Of Princeton University | Compositions and methods for cell transformation |
US5693769A (en) * | 1991-12-13 | 1997-12-02 | Transcell Technologies, Inc. | Glycosylated steroid derivatives for transport across biological membranes and process for making and using same |
IT1255450B (it) * | 1992-06-30 | 1995-10-31 | Montefarmaco Spa | Uso di acidi biliari come agenti antivirali |
WO1995003056A1 (fr) * | 1993-07-19 | 1995-02-02 | Tokyo Tanabe Company Limited | Inhibiteur de proliferation du virus de l'hepatite c |
DE4341139C1 (de) * | 1993-12-02 | 1995-04-13 | Upmeyer Hans Juergen | Dimeticon zur Behandlung von Aphthen |
US5667492A (en) * | 1994-10-07 | 1997-09-16 | Columbia Laboratories, Inc. | Use and composition of an anti-sexually transmitted diseases formulation |
US5700679A (en) * | 1996-06-07 | 1997-12-23 | Novavax, Inc. | Lipid vesicles having a bilayer containing a surfactant with anti-viral and spermicidal activity |
WO1998010744A1 (en) * | 1996-09-12 | 1998-03-19 | Simon Everard Barton | Composition comprising an antiviral or antibacterial agent for preventing transmission of diseases |
US6759434B2 (en) | 1999-09-22 | 2004-07-06 | B. Ron Johnson | Anti-infective compositions, methods and systems for treating disordered tissue |
US6211243B1 (en) | 1999-09-22 | 2001-04-03 | B. Ron Johnson | Methods for treating cold sores with anti-infective compositions |
US8173709B2 (en) * | 1999-09-22 | 2012-05-08 | Quadex Pharmaceuticals, Llc | Anti-infective methods for treating pathogen-induced disordered tissues |
US20050232868A1 (en) * | 1999-10-19 | 2005-10-20 | The Procter & Gamble Company | Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions |
CN100488517C (zh) * | 2000-03-07 | 2009-05-20 | 拉什-长老会-圣路加医学中心 | 捕获和灭活病原性微生物和精子的组合物及其制药用途 |
GB2415626B (en) * | 2001-04-11 | 2006-03-08 | Playtex Products Inc | Use of a catamenial tampon which comprises a cationic surfactant for the treatment of vaginal malodor |
US8093446B2 (en) * | 2001-04-11 | 2012-01-10 | Playtex Products, Inc. | Fibrous absorbent articles having malodor counteractant |
GB2414394B (en) * | 2001-04-11 | 2006-01-11 | Playtex Products Inc | Use of a catamenial tampon which comprises a non-ionic surfactant for the treatment of vaginal malodour |
EP1506781B1 (de) * | 2003-11-03 | 2005-02-23 | Peter-Hansen Volkmann | Vaginalpflegezusammensetzung |
AU2006284990B2 (en) * | 2005-08-29 | 2011-01-06 | Sepsicure L.L.C. | Method for treatment or prevention of conditions caused by gram-positive bacteria |
DE102006020644A1 (de) * | 2006-04-28 | 2007-10-31 | Bayer Innovation Gmbh | Antiseptikahaltige Silikonelastomere |
US8409557B2 (en) | 2006-09-28 | 2013-04-02 | Clji Ip Company, Llc | Topical formulations for the prevention of sexually transmitted disease and methods of producing the same |
US8062631B2 (en) | 2006-09-28 | 2011-11-22 | Clji I.P. Company, Llc | Topical formulations for the prevention of sexually transmitted disease and methods of producing the same |
AU2012203566B1 (en) * | 2008-03-27 | 2013-09-12 | Clji I.P. Company, Llc | Topical formulations for the prevention of sexually transmitted disease and methods of producing the same |
KR101130754B1 (ko) | 2010-06-25 | 2012-03-28 | 제일약품주식회사 | 난용성 트리사이클릭 유도체 화합물의 용해도가 향상된 약학적 조성물 |
KR101993786B1 (ko) | 2010-11-12 | 2019-06-28 | 더 유니버시티 오브 유타 리서치 파운데이션 | 윤활제의 제어된 전달을 위한 질내 장치 |
US10426761B2 (en) | 2011-04-19 | 2019-10-01 | Arms Pharmaceutical, Llc | Method for treatment of disease caused or aggravated by microorganisms or relieving symptoms thereof |
RU2013151164A (ru) | 2011-04-19 | 2015-05-27 | Армс Фармасьютикал Ллк. | Способ ингибирования вредных микроорганизмов и формирующая барьер композиция для этого способа |
CA2781379C (en) | 2012-03-26 | 2013-09-03 | Clji Ip Company, Llc | Topical formulations for the prevention of sexually transmitted disease and methods of producing the same |
US9463180B2 (en) | 2013-03-14 | 2016-10-11 | Quadex Pharmaceuticals, Llc | Treatment of molluscum contagiosum |
US9549930B2 (en) | 2013-03-14 | 2017-01-24 | Quadex Pharmaceuticals, Llc | Combined systemic and topical treatment of disordered and/or prodromal stage tissue |
US9125911B2 (en) | 2013-03-14 | 2015-09-08 | Quadex Pharmaceuticals, Llc | Combined systemic and topical treatment of disordered tissues |
KR102399883B1 (ko) * | 2021-02-09 | 2022-05-20 | 재단법인대구경북과학기술원 | 압출용 복합고분자 펠릿 및 이의 제조방법 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1161484A (en) * | 1965-08-20 | 1969-08-13 | Mediline Ag | Toilet Preparation |
SE353658B (es) * | 1967-06-13 | 1973-02-12 | Dow Corning | |
US3710795A (en) * | 1970-09-29 | 1973-01-16 | Alza Corp | Drug-delivery device with stretched, rate-controlling membrane |
US3770648A (en) * | 1971-07-12 | 1973-11-06 | Bristol Myers Co | Anhydrous aerosol foam |
BE791632A (fr) * | 1971-11-20 | 1973-05-21 | Schering Ag | Supports a base de caoutchouc siliconique pour agents medicamenteux |
US4393871A (en) * | 1977-06-27 | 1983-07-19 | Vli Corporation | Vaginal device |
US4228797A (en) * | 1978-09-25 | 1980-10-21 | Dickey Richard P | Intravaginal contraception method |
ZA827582B (en) * | 1981-11-06 | 1983-08-31 | Ansell Inc | Spermicidal condom |
JPS58103453A (ja) * | 1981-12-07 | 1983-06-20 | シンテツクス(ユ−・エス・エイ)インコ−ポレイテツド | 1−置換イミダゾ−ルを放出する使い捨て膣内避妊具 |
DE3204124A1 (de) * | 1982-02-06 | 1983-08-18 | Bayer Ag, 5090 Leverkusen | Antimykotische tampons mit hoher wirkstoff-freisetzung |
AU2272883A (en) * | 1982-12-22 | 1984-06-28 | Herpes Pharmaceutical Inc. | Pharmaceutical compositions of steriods for treatment of herpes simplex infections |
DE3346641A1 (de) * | 1983-12-23 | 1985-07-04 | Dynamit Nobel Ag, 5210 Troisdorf | Silanmodifizierte estergemische |
GB8402748D0 (en) * | 1984-02-02 | 1984-03-07 | Dunlop Ltd | Intravaginal device |
NL8600929A (nl) * | 1986-04-11 | 1987-11-02 | Fundatech Sa | Werkwijze voor het vervaardigen van een gemedicateerd wegwerp-pessarium en gemedicateerd wegwerp-pessarium. |
IT1213323B (it) * | 1986-08-07 | 1989-12-20 | Crinos Industria Farmaco | Composizione per uso locale ad atti vita' spermicida virulicida ,disinfettante e/o battericida |
US4952411A (en) * | 1987-02-25 | 1990-08-28 | Trustees Of Columbia University In The City Of New York | Method of inhibiting the transmission of AIDS virus |
GB8706313D0 (en) * | 1987-03-17 | 1987-04-23 | Health Lab Service Board | Treatment & prevention of viral infections |
FR2614525B1 (fr) * | 1987-04-29 | 1995-11-10 | Jacques Augros | Tampon en eponge elastique, notamment tampon vaginal |
US4922928A (en) * | 1988-08-17 | 1990-05-08 | Michael Burnhill | Vaginal device |
-
1989
- 1989-07-07 NO NO892826A patent/NO178843C/no unknown
- 1989-07-10 MX MX016734A patent/MX170801B/es unknown
- 1989-07-10 AR AR89314348A patent/AR243381A1/es active
- 1989-07-10 UA UA4614544A patent/UA26124A/uk unknown
- 1989-07-10 FI FI893340A patent/FI101595B/fi not_active IP Right Cessation
- 1989-07-10 YU YU135789A patent/YU47899B/sh unknown
- 1989-07-10 IL IL9091089A patent/IL90910A/en not_active IP Right Cessation
- 1989-07-10 DK DK198903402A patent/DK173527B1/da not_active IP Right Cessation
- 1989-07-10 HU HU893459A patent/HU206634B/hu not_active IP Right Cessation
- 1989-07-10 AT AT89401979T patent/ATE97570T1/de not_active IP Right Cessation
- 1989-07-10 CA CA000605271A patent/CA1341304C/fr not_active Expired - Fee Related
- 1989-07-10 MA MA21844A patent/MA22036A1/fr unknown
- 1989-07-10 EP EP89401979A patent/EP0351301B1/fr not_active Expired - Lifetime
- 1989-07-10 PT PT91108A patent/PT91108B/pt not_active IP Right Cessation
- 1989-07-10 RU SU4614544/14A patent/RU2065742C1/ru not_active IP Right Cessation
- 1989-07-10 DE DE89401979T patent/DE68910892T2/de not_active Expired - Fee Related
- 1989-07-10 IE IE221889A patent/IE63115B1/en not_active IP Right Cessation
- 1989-07-10 MY MYPI89000940A patent/MY106242A/en unknown
- 1989-07-10 TN TNTNSN89074A patent/TNSN89074A1/fr unknown
- 1989-07-10 ES ES89401979T patent/ES2062065T3/es not_active Expired - Lifetime
- 1989-07-11 ZA ZA895263A patent/ZA895263B/xx unknown
- 1989-07-11 SK SK4238-89A patent/SK423889A3/sk unknown
- 1989-07-11 PL PL89280531A patent/PL161848B1/pl unknown
- 1989-07-11 JP JP1177278A patent/JPH0774164B2/ja not_active Expired - Fee Related
- 1989-07-11 KR KR1019890009850A patent/KR0143231B1/ko not_active IP Right Cessation
- 1989-07-11 BR BR898903523A patent/BR8903523A/pt not_active IP Right Cessation
- 1989-07-11 AP APAP/P/1989/000133A patent/AP108A/en active
- 1989-07-11 OA OA59610A patent/OA09123A/xx unknown
- 1989-07-11 DD DD89330678A patent/DD283932A5/de not_active IP Right Cessation
- 1989-07-11 CN CN89104829A patent/CN1035038C/zh not_active Expired - Lifetime
- 1989-07-11 NZ NZ229891A patent/NZ229891A/xx unknown
- 1989-07-11 CZ CS894238A patent/CZ280722B6/cs not_active IP Right Cessation
- 1989-07-11 TR TR00603/89A patent/TR28353A/xx unknown
-
1992
- 1992-12-22 US US07/995,522 patent/US5439685A/en not_active Expired - Lifetime
-
1993
- 1993-02-25 LV LVP-93-140A patent/LV10573B/en unknown
- 1993-12-22 LT LTIP1660A patent/LT3754B/lt not_active IP Right Cessation
-
1994
- 1994-12-30 MD MD95-0089A patent/MD406C2/ro unknown
-
1995
- 1995-08-17 HK HK131095A patent/HK131095A/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX170801B (es) | Composicion farmaceutica para la prevencion de las enfermedades sexualmente transmisibles | |
KR100761051B1 (ko) | 점막염, 구내염 및 베체트 증후군 치료용 약학적 조성물 | |
MY100721A (en) | Therapeutic agent. | |
EP0679390A3 (en) | Sprayable topical pharmaceutical compositions | |
ES2039264T3 (es) | Preparado acuoso o pulverulento, dispersable en agua de un producto activo farmaceutico dificilmente soluble en agua y procedimiento para su obtencion. | |
CA2333869A1 (en) | Mousse composition | |
CA2304958A1 (en) | Bioadhesive compositions and methods for topical administration of active agents | |
WO1999053897A3 (en) | Topical formulation comprising poloxamers and further microbicides, and an applicator | |
AU1865100A (en) | Hyaluronate lyase used for promoting penetration in topical agents | |
CA2219065A1 (en) | Ophthalmic carrier solution | |
SI0770384T1 (en) | Solid, anhydrous, pharmaceutical compositions for vaginal use | |
BR9803233A (pt) | Preparação de combinação farmacêutica de um inibidor do trocador de sódio/hidrogênio e um medicamento para o tratamento de doenças cardiovasculares. | |
CA2294448A1 (en) | Pharmaceutical combination preparations containing erythropoietin and modified haemoglobins | |
EP2138175A3 (en) | Formulations comprising valsartan for treating diabetes or microalbuminuria | |
CA2504872A1 (en) | Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections | |
WO1994027584A3 (en) | Arylating medicaments | |
CA2120001A1 (en) | Flavopereirine-based pharmaceutical composition and use thereof for treating hiv | |
EP0343631A3 (en) | Preventing agent for human immunodeficiency virus infection comprising menfegol | |
WO2000016786A3 (en) | Oxihumic acid and its use in the treatment of various conditions | |
MY110074A (en) | Pharmacuetical formulation. | |
EP0385909A3 (en) | A kit or composition for the prevention or treatment of HIV-1 infections | |
WO2001070184A3 (en) | A composition containing monoterpenes for topical oral administration | |
AU4040195A (en) | Topical composition containing penciclovir | |
KR910004186A (ko) | 제약학적 배합물 | |
Nelson et al. | An evaluation of the analgesic efficacy of diclofenac potassium, aspirin, and placebo in postoperative dental pain |